EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer

Background: Epidermal growth factor receptor (EGFR) mutation testing is recommended in metastatic non-small cell lung cancer (NSCLC). The objective of this study was to assess changes in EGFR mutation testing patterns and tyrosine kinase inhibitor (TKI) use in US veterans with stage III-IV NSCLC bet...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Anna Hung, Kyung Min Lee, Patrick R. Alba, Yanhong Li, Anthony Z. Gao, Bradley J. Hintze, Olga V. Efimova, Rahul Shenolikar, Melissa Pavilack, Dan Simmons, Michael J. Kelley, Julie A. Lynch, Shelby D. Reed
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2021-01-01
Цуврал:	Cancer Treatment and Research Communications
Нөхцлүүд:	Cancer genomics Targeted drug therapy
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2468294221000265
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!